Real-world efficacy and safety of disitamab vedotin monotherapy or in combination with PD-1 inhibitors in locally advanced or metastatic upper tract urothelial carcinoma: a multicenter retrospective study
迪西他单抗维多汀单药治疗或联合PD-1抑制剂治疗局部晚期或转移性上尿路尿路上皮癌的真实世界疗效和安全性:一项多中心回顾性研究
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1699538
He, Shuaipeng; Wang, Cheng; Li, Xuan; Li, Can; Li, Dan; Zhang, Biao; Wan, Jianghou; Yue, Zhongjin; Wu, Gongjin; Zhang, Su; Ma, Junhai; Shang, Panfeng